(Q52881715)

English

Physician-determined patient risk of toxic effects: impact on enrollment and decision making in phase I cancer trials.

scientific article published in November 1994

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7966396

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/7966396

title

Physician-determined patient risk of toxic effects: impact on enrollment and decision making in phase I cancer trials. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7966396

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/7966396

main subject

phase I clinical trial

0 references

1 reference

1

Mick R

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7966396

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/7966396

Mark J Ratain

series ordinal

4

object named as

Ratain MJ

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7966396

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/7966396

author name string

Lane N

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7966396

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/7966396

Daugherty C

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7966396

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/7966396

language of work or name

English

0 references

publication date

1 November 1994

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7966396

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/7966396

published in

Journal of the National Cancer Institute

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7966396

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/7966396

volume

86

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7966396

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/7966396

issue

22

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7966396

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/7966396

page(s)

1685-1693

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7966396

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/7966396

Identifiers

DOI

10.1093/JNCI/86.22.1685

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7966396

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/7966396

PubMed publication ID

7966396

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7966396

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/7966396

(Q52881715)

Physician-determined patient risk of toxic effects: impact on enrollment and decision making in phase I cancer trials.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)